Welcome to our dedicated page for PLANET 13 HLDGS NEV news (Ticker: $PLNH), a resource for investors and traders seeking the latest updates and insights on PLANET 13 HLDGS NEV stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect PLANET 13 HLDGS NEV's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of PLANET 13 HLDGS NEV's position in the market.
Planet 13 Holdings Inc. (PLNH) will release its first quarter financial results on May 9, 2024, followed by a conference call discussing key business highlights, strategy, and outlook led by top executives. The Company is a prominent vertically-integrated multi-state cannabis company.
Planet 13 Holdings Inc. launches a new line of MEDIZIN branded topicals, including CBD and cannabis derived products. The topicals will be available in-store, online, and through wholesale channels. The products will be manufactured at the Planet 13 SuperStore, enhancing the customer experience. The company secured the Nevada rights to Ovation Science's patented skin delivery technology. The new topicals include MEDIZIN REST, MEDIZIN RECOVERY, MEDIZIN RELIEF, and PLANET 13 PURE CBD.
Planet 13 Holdings Inc. has received approval from the Florida Office of Medical Marijuana Use for the proposed sale of Planet 13 Florida, Inc. and the acquisition of VidaCann, , both of which own a Medical Marijuana Treatment Center License. The approval from OMMU marks the final regulatory step needed for Planet 13 to close the Transactions. The company has extended the end date of the VidaCann acquisition to May 31, 2024, and anticipates closing the Transactions in May 2024.
